Novo Nordisk Follows Eli Lilly in Dropping Insulin Prices – WebMD
March 14, 2023 – Danish drugmaker Novo Nordisk will reduce the U.S. list prices of some of its most widely used insulin products by as much as 75%, the company announced Tuesday.
The move comes after the U.S. government capped Medicare copays for insulin at $35 and drugmaker Eli Lilly announced earlier this month that it was adjusting prices and patient assistance programs to also keep costs at $35 a month or lower.
Novo Nordisk said the price of Novolog would drop 75%, and its products Levemir and Novolin would be reduced by 65%, bringing the prices of vials down to between $48.20 and $107.85 and the prices of pens down to between $91.09 and $161.77. The prescription price search engine GoodRx recently showed the cost of a month-long vial of Novolog is currently around $300.
“We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes,” said Steve Albers, Novo Nordisk senior vice president for market…
The post Novo Nordisk Follows Eli Lilly in Dropping Insulin Prices – WebMD first appeared on SEO, Marketing and Social News | OneSEOCompany.com.
source: https://news.oneseocompany.com/2023/03/14/novo-nordisk-follows-eli-lilly-in-dropping-insulin-prices-webmd_2023031442003.html
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.